Skip to content

Clinical study on the treatment of pneumonia in children with integrated traditional Chinese and Western medicine

Clinical study on the treatment of pneumonia in children with integrated traditional Chinese and Western medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082441
Enrollment
Unknown
Registered
2024-03-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Community Acquired Pneumonia

Interventions

Western medicine treatment group:None
Integrated Chinese and western medicine group:None

Sponsors

The Affiliated Hospital of Qinghai University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: ?According to the Western medical diagnostic criteria for pediatric community-acquired pneumonia;? According to the TCM syndrome differentiation criteria for pneumonia and cough, and belonging to the syndrome of wind-cold fettering the lung;?Inpatient children;?Children aged 3 years old=age=14 years old;? Legal guardians must sign the informed consent, and children who can sign their own names also need to sign.

Exclusion criteria

Exclusion criteria: ?Other lung diseases other than comorbid pneumonia;? Patients with severe primary diseases such as heart (congenital heart disease, myocarditis, etc.), liver (alanine aminotransferase (ALT), aspartate aminotransferase (AST) =1.5 times the upper limit of normal), kidney (blood urea nitrogen (BUN) > 8.2mmol/l or serum creatinine (Cr) >104umol/l, etc.), blood system, and mental illness;?Those who have a history of allergy to the drugs used;?Those who are participating in or have participated in other clinical trials within 3 months;

Design outcomes

Secondary

MeasureTime frame
Disease score;Rate and duration of disappearance of major symptoms/signs;Absence of plaque on chest CT or chest radiograph;White blood cell count;C-reactive protein;Cytokine;Length of hospital stay;Cost of treatment;Direct medical expenses;Neutrophil count;Neutrophil percentage;Procalcitonin;Serum amyloid A;

Primary

MeasureTime frame
Disease cure rate;

Countries

China

Contacts

Public ContactYang Ruyi

The Affiliated Hospital of Qinghai University

1072736190@126.com+86 138 9724 0430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026